Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data.
Authors
Jaffer A. Ajani
The University of Texas MD Anderson Cancer Center, Houston, TX;
Jaffer A. Ajani , Lisa Leung , Steve Kanters , Prianka Singh , Murat Kurt , Inkyu Kim , Mir-Masoud Pourrahmat , Howard S. Friedman , Prakash Navaratnam , Gregory Reardon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 321)
DOI
10.1200/JCO.2023.41.4_suppl.321
Abstract #
321
Poster Bd #
D2
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Prognostic value of baseline and early changes of circulating-free (cf) and circulating tumor (ct) DNA in the neoadjuvant (NA) setting of early stage colon cancer (CC).
First Author: Giacomo Bregni
Poster
2020 ASCO Virtual Scientific Program
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomized controlled trials.
First Author: Ulrich Ronellenfitsch
Poster
2019 ASCO Annual Meeting
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT).
First Author: Richard Malthaner
Poster
2017 ASCO Annual Meeting
Patterns of care and treatment outcomes of patients with stage I esophageal cancer: A National Cancer Database analysis.
First Author: Amy Catherine Moreno